Impact of Conditioning Regimen on Outcomes for Patients with Lymphoma Undergoing High-Dose Therapy with Autologous Hematopoietic Cell Transplantation
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Jun 01, 2015
- Source ID
- 10.1016/j.bbmt.2015.02.005
Entities
People
- Andrew A Lane
- Andrew S. Artz
- Brent R. Logan
- Christopher N. Bredeson
- Görgün Akpek
- Hillard M Lazarus
- Kenneth R. Cooke
- Mahmoud Aljurf
- Marcelo C Pasquini
- Philip L. Mccarthy
- Richard F. Olsson
- Vincent T. Ho
- Wael Saber
- Xiaochun Zhu
- Yi-Bin Chen
Organizations
- Actinium Pharmaceuticals (United States)
- Amgen
- Health Resources and Services Administration
- National Cancer Institute
- National Heart, Lung, and Blood Institute
- National Institute of Allergy and Infectious Diseases
- Office of Naval Research